We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Acute Lymphocytic Leukaemia

In ALL, paired PB and BM samples are required for MRD monitoring in acute phase disease. Refer to the AML sample criteria for PB and BM samples required. We currently offer BCR-ABL testing for these patients.


(Last reviewed 12th February 2018)